Form 4: CME Group Director Receives Stock Grant

Phyllis M. Lockett, a Director at CME Group Inc., was granted fully vested Class A Common Stock as part of the company's annual equity compensation program.

Summary

• Phyllis M. Lockett, a Director of CME Group Inc., received a grant of 645 shares of Class A Common Stock.
• These shares are fully vested and were issued as part of the company's annual equity compensation program for non-employee directors.
• The transaction occurred on June 25, 2026, and the shares are not subject to any vesting conditions.
• Following this transaction, Lockett beneficially owns 4,285 shares of CME Group Inc. common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine equity grant to a director as part of a standard compensation program and does not indicate significant changes in ownership or company performance.

Positives

• Director Lockett received a stock grant, indicating continued equity-based compensation for her role.
• The shares granted are fully vested, meaning immediate ownership without future conditions.
• The grant is part of a standard annual equity compensation program, suggesting a consistent approach to director remuneration.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common practice in the financial services industry, aligning director interests with shareholder value.

Stakeholder Impact

• Shareholders: The grant reinforces director alignment with shareholder interests through equity ownership.
• Directors: Phyllis M. Lockett receives compensation in the form of vested stock.

Key Dates

Keywords

CME Group, Phyllis M. Lockett, Director, Stock Grant, Equity Compensation, Form 4, Beneficial Ownership, Class A Common Stock